HEC88473
Asset
GLP-1 receptor agonist
- Stage
- Phase 2
- Modality
- Peptide
- Target
- Insulin/IGF-1 signalling
- 1
- Indication
- 66
- Trials
- 1
- Developer
Indications
1Type 2 diabetes
Phase 2, Completed, NCT06148649, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Trials66
- Evidence for its targets3
- Competitors12
- Aging relevance1
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.